You are here
- Home
- Therapy Areas
- Oncology/Infection
This group of 20 plus NCI studies does not have a protocol title.
- Disease
- colorectal cancer
- Drug Name
- RECENTIN
- Generic Name
- AZD2171
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- II
- Start Date
- Oct 5, 2005
- Study Name
- D8480C00010
- Study Id
- D8480C00010
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
